Stemline Therapeutics Inc (NASDAQ:STML)

16.11
Delayed Data
As of Apr 17
 -0.14 / -0.86%
Today’s Change
10.50
Today|||52-Week Range
18.94
-5.57%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Stemline Therapeutics Inc have a median target of 50.00, with a high estimate of 55.00 and a low estimate of 35.00. The median estimate represents a +210.37% increase from the last price of 16.11.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Stemline Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.46
Sales
$50.2K
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.52%
 
 
 
 
 
 
Growthannually 14.13%
 
 
 
 
 

Sales

Growthquarterly -58.66%
 
 
 
 
 
 
Growthannually -51.78%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account